As of the time of writing, retatrutide has not received marketing authorisation from the MHRA, the EMA, or the US Food and Drug Administration (FDA)
It is an experimental compound that has been investigated for inflammatory bowel disease and soft tissue healing, although there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions
Assays were performed following the manufacturers protocol for each kit
Schedule a free consultation today
What are the oral and dental implications
Key Takeaway: GLP-1 medications mimic a natural gut hormone to help regulate appetite, slow digestion, and manage blood sugar, which may support sustainable weight loss when combined with lifestyle changes